“…For example, (+)-liphagal is a selective phosphoinositide-3-kinase -inhibitor (Marion et al, 2006), cyclopenta [b]benzofuran compounds possess antitumour and antiviral activities (Kim et al, 2006), while derivatives of egonol have antioxidant and anti-inflammatory activities (Timmers et al, 2015). Synthetic benzofuran derivatives are found to possess antitumour and anticancer (Shi et al, 2016;Marquès et al, 2016;Napió rkowska et al, 2019;Asadi et al, 2017), antimicrobial (Asadi et al, 2017;He et al, 2017;Xu et al, 2019) and antitubercular (Xu et al, 2019) activities. Some synthetic benzofuran derivatives have been investigated in the role of osteogenic (Marquè s et al, 2016;Kushwaha et al, 2018;Modukuri et al, 2017) or vasorelaxant (Hassan et al, 2014) agents.…”